Federal award
ARMIS BIOPHARMA, INC.
HDTRA123C0013
Contract
Obligated and Ceiling
- Obligated (net)
- $4,759,320.63
- Ceiling (potential value, not spending)
- $20,289,348.85
- Current value
- $5,759,320.63
- Gross positive obligations
- $4,759,320.63
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ARMIS BIOPHARMA, INC. · WMR2HDJ79576
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ARMIS BIOPHARMA, INC. · WMR2HDJ79576
- Awarding agency
- Department of War · sub-agency 9761 · office HDTRA1
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AC32 · NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- HDTRA123C0013
- Award type code
- D
- Actions
- 4 · Aug 8, 2023 to Feb 6, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 6, 2025 | FY2025 | P00003 | B | $0.00 | — |
| Jun 12, 2024 | FY2024 | P00002 | C | $2,403,468.23 | — |
| Oct 27, 2023 | FY2024 | P00001 | M | $0.00 | — |
| Aug 8, 2023 | FY2023 | 0 | — | $2,355,852.40 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.